Chimerix Inc (NAS:CMRX)
$ 1 -0.05 (-4.76%) Market Cap: 89.63 Mil Enterprise Value: -63.91 Mil PE Ratio: 0 PB Ratio: 0.51 GF Score: 55/100

Q3 2021 Chimerix Inc Earnings Call Transcript

Nov 04, 2021 / 12:30PM GMT
Release Date Price: $6.1 (+3.74%)
Operator

Good morning, ladies and gentlemen, and welcome to the Chimerix Third Quarter 2021 Earnings Conference Call.

I would now like to introduce you to your host for today's call, Michelle LaSpaluto, Vice President of Strategic Planning and Investor Relations at Chimerix. Please proceed.

Michelle LaSpaluto
Chimerix, Inc. - VP of Strategic Planning & IR

Thank you. Good morning, everyone, and welcome to the Chimerix Third Quarter 2021 Financial and Operating Results Conference Call. This morning, we issued our third quarter financial results press release and a separate release reporting positive top line results from the ONC201 recurrent H3 K27M-mutant glioma. You can access those press releases in our Investor Relations section of the website.

With me on today's call are President and Chief Executive Officer, Mike Sherman; Chief Financial and Business Officer, Mike Andriole; Allen Melemed, our Chief Medical Officer; and Josh Allen, our Chief Technology Officer of Imipridones.

Before we begin, I would like to remind you that the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot